Pet isotope pylarify F-18
Active Awarded Last action
- Contract number
- 36C24426F0056
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $505,221
Award facts
- Contract value 54% obligated
-
- $505,220.80 Current, with exercised options
- $938,267.20 Potential, with all options
- Completion date 41% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, PA, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $72,174 | |
| Original award | $433,046 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 4, issued a $938,267.20 delivery order to Progenics Pharmaceuticals Inc. on January 31, 2026, for supply of PYLARIFY (piflufolastat F-18), a positron emission tomography imaging agent used to detect prostate cancer.
The order is placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered multi-agency vehicle. Place of performance is Lebanon, PA. The order runs through December 31, 2027, and is priced as firm fixed-price.
Progenics Pharmaceuticals Inc. operates as a division of Lantheus Medical Imaging, Inc. and holds a quasi-monopoly position as the sole authorized federal manufacturer of PYLARIFY. The company supplies radiopharmaceutical diagnostic imaging agents to the federal government exclusively at the prime level, with no subcontract footprint. Manufacturing and distribution are performed at facilities in North Billerica and Bedford, Massachusetts, supporting delivery to VA medical centers nationwide.
Quick answers
Who was awarded contract 36C24426F0056?
36C24426F0056 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on January 31, 2026.
How much is contract 36C24426F0056 worth?
The government has obligated $505,221 on 36C24426F0056. Its potential value, with all options, is $938,267.
Is contract 36C24426F0056 an order under another contract?
Yes. 36C24426F0056 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24426F0056 competed?
The extent of competition for 36C24426F0056 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award